PLAINSBORO, N.J., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will feature the Auragen(TM) line of cortical electrodes for brain mapping at the 2009 Congress of Neurological Surgeons, held October 24 - October 29, 2009 in New Orleans, Louisiana. Auragen(TM) electrodes have received 510(k) clearance from the United States Food and Drug Administration (FDA) and CE Mark Certification in the European Union. Auragen(TM) electrodes have also received FDA clearance for conditional use under Magnetic Resonance Imaging (MRI).
